Filed 11mo ago· Jun 23, 2025
25 days to disclose
Robert P. Bresnahan Jr.
RHousePennsylvania-08
↑bought
Veeva Systems
VEEV
$1K-$15K
−52.2% vs S&P 500
Trade dateMay 29, 2025
Stock
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.












































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jun 23, 2025 11mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Veeva Systems VEEV Stock | May 29, 2025 25 days to disclose | Bad buy·−$3.2K-40.0% −52.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Veeva Systems VEEV Stock | May 16, 2025 24 days to disclose | Flat·+0.0% +11.6% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | IDEXX Laboratories IDXX Stock | May 15, 2025 25 days to disclose | Good buy·+$556+6.9% −6.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Baxter International BAX Stock | May 15, 2025 25 days to disclose | Bad buy·−$3.6K-45.3% −59.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Centene CNC | May 15, 2025 25 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Molina Healthcare MOH | May 15, 2025 25 days to disclose | Bad buy·−$3K-37.1% −51.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Humana HUM | May 15, 2025 25 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Cooper Companies COO The Cooper Companies | May 15, 2025 25 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | May 15, 2025 25 days to disclose | Bad buy·−$1.2K-15.1% −28.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 9, 2025 12mo ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Becton Dickinson BDX Common Stock | May 15, 2025 25 days to disclose | Good buy·+$542+6.8% −7.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Medtronic MDT | May 15, 2025 16 days to disclose | Bad buy·−$864-10.8% −24.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | IQVIA Holdings IQV IQVIA Holdings, Inc. | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | CVS Health CVS Stock | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Ge Healthcare GEHC Common Stock | May 15, 2025 16 days to disclose | Bad buy·−$1.2K-15.5% −29.3% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Charles River Laboratories International CRL International, Inc. | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Agilent Technologies A Stock | May 15, 2025 16 days to disclose | Good buy·+$377+4.7% −9.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Danaher DHR | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Elevance Health ELV Elevance Health, Inc. | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Zimmer Biomet ZBH Common Stock | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Labcorp Holdings LH | May 15, 2025 16 days to disclose | Good buy·+$348+4.3% −9.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | UnitedHealth Group UNH Common Stock | May 15, 2025 16 days to disclose | Flat·+0.0% +13.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Thermo Fisher Scientific TMO Stock | May 15, 2025 16 days to disclose | Good buy·+$5.5K+16.8% +2.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 31, 2025 1.0y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Mettler Toledo International Inc/ MTD Common Stock | May 15, 2025 16 days to disclose | Good buy·+$1.3K+16.1% +2.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Viatris VTRS | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Align Technology ALGN Stock | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Bio-Techne TECH | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Cardinal Health CAH Cardinal Health, Inc. | Apr 8, 2025 30 days to disclose | Good buy·+$4.3K+53.2% +41.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Charles River Laboratories International CRL International, Inc. | Apr 8, 2025 30 days to disclose | Good buy·+$15.3K+47.0% +35.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Danaher DHR | Apr 8, 2025 30 days to disclose | Flat·+0.5% −11.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Edwards Lifesciences EW Common Stock | Apr 8, 2025 30 days to disclose | Good buy·+$2K+25.2% +13.5% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Henry Schein HSIC | Apr 8, 2025 30 days to disclose | Good buy·+$1.2K+15.5% +3.9% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | IQVIA Holdings IQV IQVIA Holdings, Inc. | Apr 8, 2025 30 days to disclose | Good buy·+$7.1K+21.8% +10.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Labcorp Holdings LH | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Revvity RVTY Revvity, Inc. | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Stryker SYK | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Stryker SYK | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Waters WAT | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | West Pharmaceutical Services WST Common Stock | Apr 8, 2025 30 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Zimmer Biomet ZBH Common Stock | Apr 8, 2025 30 days to disclose | Bad buy·−$1.6K-19.4% −31.1% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Centene CNC | Apr 8, 2025 30 days to disclose | Bad buy·−$906-11.3% −23.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 8, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | UnitedHealth Group UNH Common Stock | Apr 8, 2025 30 days to disclose | Bad buy·−$10.1K-31.1% −42.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Dexcom DXCM | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Thermo Fisher Scientific TMO Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Becton Dickinson BDX Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Medtronic MDT | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Mettler Toledo International Inc/ MTD Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | IDEXX Laboratories IDXX Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Agilent Technologies A Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Ge Healthcare GEHC Common Stock | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Steris STE | Feb 25, 2025 30 days to disclose | Bad buy·−$542-6.8% −6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Align Technology ALGN Stock | Feb 25, 2025 30 days to disclose | Bad buy·−$567-7.1% −6.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Labcorp Holdings LH | Feb 25, 2025 30 days to disclose | Good buy·+$130+1.6% +1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | IQVIA Holdings IQV IQVIA Holdings, Inc. | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Humana HUM | Feb 25, 2025 30 days to disclose | Good buy·+$2K+25.2% +25.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Revvity RVTY Revvity, Inc. | Feb 25, 2025 30 days to disclose | Bad buy·−$1.1K-14.2% −13.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Bio-Techne TECH | Feb 25, 2025 30 days to disclose | Bad buy·−$1.9K-23.2% −22.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Teleflex TFX | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Cigna CI The Cigna Group | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | HCA Healthcare HCA HCA Healthcare, Inc. | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Thermo Fisher Scientific TMO Stock | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | UnitedHealth Group UNH Common Stock | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Viatris VTRS | Feb 25, 2025 30 days to disclose | Good buy·+$3.8K+48.0% +48.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Dexcom DXCM | Feb 25, 2025 30 days to disclose | Bad buy·−$1.4K-17.6% −17.4% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | West Pharmaceutical Services WST Common Stock | Feb 25, 2025 30 days to disclose | Good buy·+$3.4K+42.0% +42.2% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Waters WAT | Feb 25, 2025 30 days to disclose | Bad buy·−$658-8.2% −8.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Medtronic MDT | Feb 25, 2025 30 days to disclose | Bad buy·−$1.2K-15.1% −14.8% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | IDEXX Laboratories IDXX Stock | Feb 25, 2025 30 days to disclose | Good buy·+$1.5K+19.1% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | Ge Healthcare GEHC Common Stock | Feb 25, 2025 30 days to disclose | Bad buy·−$2.6K-32.2% −31.9% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Danaher DHR | Feb 25, 2025 30 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Mar 27, 2025 1.2y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↑bought | CVS Health CVS Stock | Feb 25, 2025 30 days to disclose | Good buy·+$3.4K+42.0% +42.3% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | ResMed RMD | Jan 13, 2025 31 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Molina Healthcare MOH | Jan 13, 2025 31 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Cigna CI The Cigna Group | Jan 13, 2025 31 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Elevance Health ELV Elevance Health, Inc. | Jan 13, 2025 31 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Medpace Holdings MEDP Stock | Jan 13, 2025 31 days to disclose | price pending | $1K-$15K midpoint $8K |
Feb 13, 2025 1.3y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | UnitedHealth Group UNH Common Stock | Jan 13, 2025 31 days to disclose | Flat·+0.0% +5.0% vs S&P 500 | $1K-$15K midpoint $8K |